💈 HairBase▦ Browse all
Hair guideResearchKetoconazole shampoo

Ketoconazole shampoo — Research & evidence

✓ Medically reviewed📅 Last updated: 2026-06-14⏱ 4 min read
💡 Quick answer

The landmark clinical studies, treatment history and latest research for Ketoconazole shampoo — fact-checked and sourced.

Research & evidence

How treatment evolved
1981Ketoconazole (Janssen) is first approved as an oral antifungal in the US, establishing the imidazole drug whose topical form is later studied for hair loss; its known inhibition of steroidogenesis/androgen synthesis seeds the antiandrogen rationale.
1990FDA approves Nizoral (ketoconazole) 2% shampoo (NDA 019927, Janssen) as a prescription topical for seborrheic dermatitis/dandruff. Its use in androgenetic alopecia has always been off-label, not an FDA-approved hair-loss indication.
1998Piérard-Franchimont et al. publish the first clinical report in Dermatology suggesting 2% ketoconazole shampoo improves hair density and anagen ratio in male AGA comparably to minoxidil, framing scalp Malassezia/inflammation as a contributor.
2002Khandpur et al. (J Dermatol) report a 100-man comparative trial showing ketoconazole as adjunct enhances response, and finasteride-containing regimens outperform monotherapy — cementing ketoconazole's role as an adjunct rather than a stand-alone therapy.
2020Fields et al. publish the first systematic review (Dermatologic Therapy) pooling 7 studies; concludes ketoconazole shampoo shows potential benefit in AGA but evidence is limited, mostly small/low-quality, and best positioned as adjunctive to minoxidil/finasteride.
Key clinical studies
Piérard-Franchimont et al., 19981998
Comparative controlled clinical study in men with grade III vertex AGA (~39 subjects, aged ~21-33); 2% ketoconazole shampoo vs unmedicated shampoo, with/without 2% minoxidil
Hair density, hair shaft diameter, and the proportion of anagen (growing) follicles were improved 'almost similarly' by the 2% ketoconazole and the 2% minoxidil regimens; scalp sebum (casual) level appeared reduced with ketoconazole. Authors explicitly called for larger controlled study, implicating Malassezia-driven inflammation.
Dermatology (Karger), 1998;196(4):474-477
Khandpur et al., 20022002
Open, randomized, parallel-group trial in 100 men with Hamilton grade II-IV AGA; oral finasteride 1 mg/day, topical 2% minoxidil, and 2% ketoconazole shampoo, alone and in combination
Finasteride-containing arms (alone or combined with minoxidil or ketoconazole) showed statistically significant improvement (p<0.05) versus minoxidil alone; combining agents with different mechanisms produced superior results, supporting ketoconazole shampoo as an adjunct. No significant drug-related side effects reported.
The Journal of Dermatology, 2002;29(8):489-498
Fields et al. (Fields, Vonu, Monir, et al.), 20202020
Systematic review (MEDLINE); 47 papers screened, 7 included — 2 murine studies (40 animals) and 5 human studies (318 participants total)
Murine studies showed a significant increase in the mean ratio of hair regrowth to denuded area with ketoconazole vs controls; human studies collectively support potential efficacy of 2% ketoconazole shampoo in AGA. Authors emphasize the evidence base is limited/heterogeneous and recommend ketoconazole as a complementary adjunct to minoxidil and finasteride rather than monotherapy.
Dermatologic Therapy, 2020;33(1):e13202 (PMID 31858672)
Latest research: Recent work (2023-2026) has largely been synthesis and delivery-focused rather than new large RCTs: narrative/clinical reviews (e.g., Gupta et al., 2025) reaffirm 2% ketoconazole shampoo as an evidence-supported adjunct acting via antifungal, anti-inflammatory, and local antiandrogenic (DHT-pathway) effects, while formulation research explores nanostructured lipid carriers and PLGA/ketoconazole nanoparticles to improve scalp/follicular penetration. The consistent caveat is that high-quality, adequately powered head-to-head trials are still lacking.

Summaries reflect published, peer-reviewed research and are not medical advice. See the linked sources for details.

Try the free self-check →

Explore more

Not medical advice. General education only; it does not replace diagnosis or treatment by a licensed professional. Consult a board-certified dermatologist before starting, stopping or changing any treatment.

⚠️ When to see a doctor — don’t self-treat

  • Sudden patchy or circular bald spots
  • Redness, scaling, pus, pain or itch (possible scarring alopecia — treat urgently)
  • Broken hairs or rapid loss
  • Loss with body-wide signs (weight loss, fatigue, cycle changes, acne, extra hair)
  • Loss right after a new medication
  • Any hair loss in a child
Try the free self-check →
Try the free self-check →